Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00453141
Status:
COMPLETED
Last Update Posted:
2009-11-10
First Post:
2007-03-26
Brief Title:
Betamethasone Dosing Interval - 12 or 24 Hours
Sponsor:
The Cooper Health System
Organization:
The Cooper Health System
Study Overview
Official Title:
Betamethasone Dosing Interval - 12 or 24 Hours
Status:
COMPLETED
Status Verified Date:
2009-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if there may be a benefit to the newborn if betamethasone is given 12 hours apart instead of 24 hours apart
Detailed Description:
Betamethasone is a medicine given to women expected to deliver after 24 but before 34 weeks of pregnancy It is very advantageous in preventing or decreasing the many problems these small babies may face if born early Betamethasone makes breathing easier for them also decreases the chance of them bleeding in the head and makes their chances of survival better This medicine is used routinely in pregnancy but the best timing between doses in not well established The standard dosing schedule involves giving 2 injections of 12mg of the medicine 24 hours apart However many women deliver before reaching the 24-hour mark despite the doctors best efforts to try and delay delivery and therefore miss the opportunity for the 2nd dose
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None